Listed

Mayville Engineering Company, Inc.: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Aug 5, 2020 and accepted by EDGAR at Aug 5, 2020, 17:01 ET.

Share

Management's discussion and analysis

As filed, 45,992 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to assist in the understanding and assessing the trends and significant changes in our results of operations and financial condition. Historical results may not be indicative of future performance. This discussion includes forward-looking statements that reflect our plans, estimates and beliefs. Such statements involve risks and uncertainties. Our actual results may differ materially from those contemplated by these forward-looking statements as a result of various factors, including those set forth in “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019, as such were previously supplemented and amended in Part II, Item 1A, “Risk Factors” of our Quarterly Report on Form 10-Q for the three months ended March 31, 2020, and “Cautionary Statement Regarding Forward-Looking Statements” and “Risk Factors” in Part II Item 1A of this Quarterly Report on Form 10-Q. This discussion should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019 and our unaudited condensed consolidated financial statements and the notes thereto included in Part I, Item I of this Quarterly Report on Form 10-Q. In this discussion, we use certain non-GAAP financial measures. Explanation of these non-GAAP financial measures and reconciliation to the most directly comparable GAAP financial measures are included in this Management Discussion and Analysis of Financial Condition and Results of Operations. Investors should not consider non-GAAP financial measures in isolation or as substitutes for financial information presented in compliance with GAAP.

All amounts are presented in thousands except share amounts, per share data, years and ratios.

Overview

MEC is a leading U.S.-based value-added manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components. Our customers operate in diverse end markets, including heavy-and medium-duty commercial vehicles, construction, powersports, agriculture, military and other end markets. We have developed long-standing relationships with our blue-chip customers based upon a high level of experience, trust and confidence.

Our one operating segment focuses on producing metal components that are used in a broad range of heavy-and medium-duty commercial vehicles, construction, powersports, agricultural, military and other products.

In May 2019, we completed our IPO. In conjunction with the IPO, the Company’s legacy business converted from an S corporation to a C corporation. As a result, the consolidated business is subject to paying federal and state corporate income taxes on its taxable income from May 9, 2019 forward.

COVID-19 Impact

COVID-19 has had and will continue to have a negative impact on our business, financial condition, cash flows, and results of operations, although the full extent is uncertain.

For the three and six-month periods ended June 30, 2020, net sales reflected the significant disruption we encountered primarily due to COVID-19 with customer shutdowns, demand changes, and continued destocking, which were most apparent in the Commercial Vehicle, Agriculture and Construction end markets served. Despite MEC and its customer base carrying the essential business designation, customer production facilities shut down 5 – 6 weeks on average during the current quarter due to COVID-19. As a result, MEC temporarily halted production at some of its facilities. Customer manufacturing facilities gradually reopened toward the end of the quarter, but MEC production volumes remained below pre-pandemic levels as of quarter end. Despite the decline in volumes for the second quarter, all existing customer relationships and manufacturing programs remain intact. While end markets have started to stabilize, we have improved our near- and long-term cost structure through facility and process optimization and are actively working with our customers to grow our partnerships while pursuing incremental sales through a wide range of new customer and market opportunities.

The future financial effects of COVID-19 are unknown due to many factors. These factors include uncertainty of the effectiveness of governmental actions to address COVID-19, including health, monetary and fiscal policies, the effect of elevated levels of sovereign and state debt, capital market disruptions, changes in demand and pricing, trade agreements, other geopolitical events, and volatility in the price of many commodities. As a result, predicting the Company’s forecasted financial performance is difficult and subject to many assumptions.

The Company’s first priority has been to safeguard the health and well-being of its employees while fulfilling its obligations as an essential business serving its customer base. This proactive approach has kept employees safe and production facilities operational based on customer demand. Our goal is to continue to successfully manage through the effects of COVID-19 and strengthen our position serving customers in the future.

How We Assess Performance

Net Sales. Net sales reflect sales of our components and products net of allowances for returns and discounts. Several factors affect our net sales in any given period, including general economic conditions, weather, timing of acquisitions and the production schedules of our customers. Net sales are recognized at the time of shipment to the customer.

Manufacturing Margins. Manufacturing margins represents net sales less cost of sales. Cost of sales consists of all direct and indirect costs used in the manufacturing process, including raw materials, labor, equipment costs, depreciation, lease expenses, subcontract costs and other directly related overhead costs. Our cost of sales is directly affected by the fluctuations in commodity prices, primarily sheet steel and aluminum, but these changes are largely mitigated by contractual agreements with our customers that allow us to pass through these price changes based upon certain market indexes.

Depreciation and Amortization. We carry property, plant and equipment on our balance sheet at cost, net of accumulated depreciation and amortization. Depreciation on property, plant and equipment is computed on a straight-line basis over the estimated useful life of the asset. Amortization expense is the periodic expense related to leasehold improvements and intangible assets. Leasehold improvements are amortized over the lesser of the life of the underlying asset or the remaining lease term. Our intangible assets were recognized as a result of certain acquisitions and are generally amortized on a straight-line basis over the estimated useful lives of the assets.

Other Selling, General, and Administrative Expenses. Other selling, general and administrative expenses consist primarily of salaries and personnel costs for our sales and marketing, finance, human resources, information systems, administration and other certain managerial employees and certain corporate level administrative expenses such as incentive compensation, audit, accounting, legal and other consulting and professional services, travel, and insurance.

Other Key Performance Indicators

EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin

EBITDA represents net income before interest expense, provision (benefit) for income taxes, depreciation and amortization. EBITDA Margin represents EBITDA as a percentage of net sales for each period.

Adjusted EBITDA represents EBITDA before transaction fees incurred in connection with the acquisition of Defiance Metal Products Co., Inc. (DMP) and the IPO, the loss on debt extinguishment relating to our December 2018 credit agreement, non-cash purchase accounting charges including costs recognized on the step-up of acquired inventory and contingent consideration fair value adjustments, one-time increases in deferred compensation and long term incentive plan expenses related to the IPO, stock-based compensation, and restructuring expenses related to the closure of the Greenwood facility. Adjusted EBITDA Margin represents Adjusted EBITDA as a percentage of net sales for each period. These metrics are supplemental measures of our operating performance that are neither required by, nor presented in accordance with, GAAP. These measures should not be considered as an alternative to net income or any other performance measure derived in accordance with GAAP as an indicator of our operating performance. We present Adjusted EBITDA and Adjusted EBITDA Margin as management uses these measures as key performance indicators, and we believe they are measures frequently used by securities analysts, investors and other parties to evaluate companies in our industry. These measures have limitations as analytical tools and should not be considered in isolation or as substitutes for analysis of our results as reported under GAAP.

Starting in the first quarter of 2020, we excluded stock-based compensation expense from Adjusted EBITDA. Management excludes this charge when evaluating the performance of the business because it is a non-cash charge, and the Company is able to fund vesting obligations through treasury shares. Further, the exclusion of these charges aligns with the calculation of Adjusted EBITDA for purposes of our covenant calculations under the Credit Agreement. And finally, revaluations of grant date fair values can vary significantly with the passage of time without any accounting impact. For example, the fair value of the stock-based compensation awards granted in May 2019 would have been less than half of that value had they been granted at the end of this quarter.

Our calculation of EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin may not be comparable to the similarly named measures reported by other companies. Potential differences between our measures of EBITDA and Adjusted EBITDA compared to other similar companies’ measures of EBITDA and Adjusted EBITDA may include differences in capital structure and tax positions.

The following table presents a reconciliation of net loss, the most directly comparable measure calculated in accordance with GAAP, to Adjusted EBITDA, and the calculation of Adjusted EBITDA Margin for each of the periods presented.

(in thousands)

Three Months Ended June 30, 2020 2019 Six Months Ended June 30, 2020 2019
Net loss $(7,014) $(15,284) $(6,964) $(12,825)
Interest expense 637 1,991 1,463 4,824
Benefit for income taxes (2,525) (3,513) (1,834) (2,744)
Depreciation and amortization 8,159 8,704 16,439 16,355
EBITDA (743) (8,102) 9,104 5,610
Loss on the extinguishment of debt — 154 — 154
Costs recognized on step-up of acquired inventory — — — 395
Contingent consideration revaluation — 2,674 — 3,544
Deferred compensation expense specific to IPO — 10,159 — 10,159
Long term incentive plan expense specific to IPO — 9,921 — 9,921
Other IPO and DMP acquisition related expenses — 2,576 — 4,388
IPO stock-based compensation expense 304 421 1,029 421
Stock based compensation expense 855 376 1,712 376
Greenwood restructuring charges 1,838 — 1,838 —
Adjusted EBITDA $2,254 $18,179 $13,683 $34,968
Net sales $62,582 $145,130 $171,187 $288,862
EBITDA Margin -1.2% -5.6% 5.3% 1.9%
Adjusted EBITDA Margin 3.6% 12.5% 8.0% 12.1%

Consolidated Results of Operations

Three Months Ended June 30, 2020 Compared to Three Months Ended June 30, 2019

(in thousands)

Three Months Ended June 30, 2020 Amount % of Net Sales 2019 Amount % of Net Sales Increase (Decrease) Amount Change % Change
Net sales $62,582 100.0% $145,130 100.0% $(82,548) -56.9%
Cost of sales 63,736 101.8% 124,595 85.9% (60,859) -48.8%
Manufacturing margins (1,154) -1.8% 20,535 14.1% (21,689) -105.6%
Amortization of intangibles 2,677 4.3% 2,677 1.8% — 0.0%
Profit sharing, bonuses and deferred compensation 1,194 1.9% 22,830 15.7% (21,636) -94.8%
Employee stock ownership plan (income) expense (675) -1.1% 1,500 1.0% (2,175) -145.0%
Other selling, general and administrative expenses 4,552 7.3% 7,506 5.2% (2,954) -39.4%
Contingent consideration revaluation — 0.0% 2,674 1.8% (2,674) -100.0%
Loss from operations (8,902) -14.2% (16,652) -11.5% (7,750) -46.5%
Interest expense (637) 1.0% (1,991) 1.4% (1,354) -68.0%
Loss on the extinguishment of debt — 0.0% (154) 0.1% (154) -100.0%
Benefit for income taxes (2,525) -4.0% (3,513) -2.4% (988) -28.1%
Net loss and comprehensive loss $(7,014) -11.2% $(15,284) -10.5% $(8,270) -54.1%
EBITDA $(743) -1.2% $(8,102) -5.6% $7,359 90.8%
Adjusted EBITDA $2,254 3.6% $18,179 12.5% $(15,925) -87.6%

Net Sales. Net sales were $62,582 for the three months ended June 30, 2020 as compared to $145,130 for the three months ended June 30, 2019, a decrease of $82,548, or 56.9%. This change is due to volume reductions across nearly all end markets served driven by COVID-19, which forced customer manufacturing facility shutdowns for 5-6 weeks on average during the quarter. These shutdowns occurred despite MEC and its customers carrying the essential business designation. Customer manufacturing facilities reopened at reduced volume levels, with gradual increases. As of quarter end, customer manufacturing volumes remained lower than pre COVID-19 volume levels. In addition to the impacts of COVID-19, customer destocking continued during the quarter. This was most apparent in the Commercial Vehicle, Agriculture, and Construction end markets served.

Manufacturing Margins. Manufacturing margins were ($1,154) for the three months ended June 30, 2020 as compared to $20,535 for the three months ended June 30, 2019, a decrease of $21,689, or 105.6%. The decline was driven by the aforementioned sales volume reductions resulting in significant under absorbed manufacturing costs. In addition, $1,838 of restructuring costs was charged to cost of sales in the current period related to the Greenwood facility closure including $844 for the loss on disposal of manufacturing equipment, $231 for severance and retention bonus, $638 for planned inventory disposal, and $125 for mostly related costs to close this facility and relocate equipment to other facilities. These charges were slightly offset by a modest adjustment to the COVID-19 specific reserve related to health care.

Manufacturing margin percentages were a negative 1.8% for the three months ended June 30, 2020, as compared to 14.1% for the three months ended June 30, 2019, a decline of 1,590 basis points. This decline was mostly attributable to lower sales volumes due to COVID-19 along with the $1,838 of restructuring charges to cost of sales in the current period related to the Greenwood facility closure. Based on the cost reduction initiatives enacted, the Company believes manufacturing margin percentages should improve beyond historical percentages when volumes return to historical levels.

As a result of the Greenwood facility closure, future earnings and cash flows will no longer be impacted by the depreciation associated with the assets disposed of or the facility, which the Company plans to sell. Assets disposed of had a net book value of $2,249 with a remaining useful life of approximately 3 years resulting in approximately $750 of annual depreciation expense that will no longer be incurred. The facility has a net book value of $3,263 as of June 30, 2020 with a remaining useful life of approximately 28 years resulting in approximately $115 of annual depreciation expense that will no longer be incurred. In addition, the Company incurred approximately $800 annually for facility maintenance including building and ground maintenance and utilities. Total personnel costs, including benefits associated with the Greenwood facility, were approximately $2,250 for the first quarter 2020 resulting in approximately $9,000 of annual personnel expenses specific to the Greenwood facility that will no longer be incurred. All customer components manufactured at the Greenwood facility are being re-distributed amongst five other MEC manufacturing facilities and will be supported by personnel at those facilities, the costs of which will offset the majority of the $9,000 of annual Greenwood personnel costs being eliminated. The aforementioned depreciation, facility maintenance and personnel expenses are classified as cost of sales.

Amortization of Intangibles Expense. Amortization of intangibles expense was $2,677 for both the three months ended June 30, 2020 and 2019.

Profit Sharing, Bonuses and Deferred Compensation Expenses. Profit sharing, bonuses, and deferred compensation expenses were $1,194 for the three months ended June 30, 2020 as compared to $22,830 for the three months ended June 30, 2019, a decrease of $21,636, or 94.8%. This change was primarily driven by $20,080 of one-time IPO expenses incurred in the prior year including $10,159 for deferred compensation and $9,921 for long-term incentive plan. The remaining decrease of $1,556 is due to the elimination of executive bonus and most discretionary gain sharing accruals as a result of lower financial performance mostly attributable to adverse financial impacts of COVID-19.

Employee Stock Ownership Plan (Income) Expense. Employee stock ownership plan (income) expense was ($675) for the three months ended June 30, 2020 as compared to $1,500 for the three months ended June 30, 2019, a decrease of $2,175, or 145.0%. Prior to December 31, 2019, the annual ESOP contribution was discretionary except that it must be at least 3% of the compensation for all safe harbor participants for the plan year. Beginning in 2020, all contributions are discretionary. The change is due to the decision to eliminate the discretionary accrual made for the three months ended March 31, 2020 during the three month period ended June 30, 2020 as a result of lower forecasted financial performance for the fiscal year 2020 due to the impacts of COVID-19.

Other Selling, General and Administrative Expenses. Other selling, general and administrative expenses were $4,552 for the three months ended June 30, 2020 as compared to $7,506 for the three months ended June 30, 2019, a decrease of $2,954, or 39.4%. The prior year period includes an additional $2,576 of one-time other IPO and DMP acquisition related expenses. Excluding these one-time charges, these expenses decreased $378 driven by synergies achieved through the integration of DMP, lower travel and entertainment expenses in the current period due to COVID-19 restrictions, and other cost saving initiatives.

Contingent Consideration Revaluation. The DMP purchase agreement provided for a payout to the previous shareholders of DMP of $7,500, but not more than $10,000 if a certain level of EBITDA was generated during the twelve-month period ended September 30, 2019. We estimated the fair value of the contingent consideration payable balance of $6,076 as of the acquisition date of December 14, 2018. We then remeasured the fair value each quarter through September 30, 2019, with the change recorded as a contingent consideration revaluation adjustment. For the three months ended June 30, 2019, the contingent consideration payable was revalued to $9,598, resulting in $2,674 of a revaluation adjustment for the three months ended June 30, 2019.

At the end of the earnout period, and as agreed to by DMP’s former shareholders, it was determined that DMP’s EBITDA fell short of the payout threshold. As a result, the contingent consideration payable balance was subsequently adjusted to zero, reversing the contingent consideration revaluation adjustments recorded through the periods covered in this report.

Interest Expense. Interest expense was $637 for the three months ended June 30, 2020 as compared to $1,991 for the three months ended June 30, 2019, a decrease of $1,354, or 68.0%. The change is due to lower borrowings during the second quarter of 2020 as compared to the second quarter of 2019 along with lower interest rates attributable to the more favorable terms afforded under the Credit Agreement.

Benefit for Income Taxes. Income tax benefit was $2,525 for the three months ended June 30, 2020 as compared to $3,513 for the three months ended June 30, 2019. The change is due to a greater pretax loss incurred during the prior year period driven by one-time IPO related charges. As of June 30, 2020, our federal operating loss (NOL) carryforward was approximately $23,600 driven by the pretax losses incurred in the current period along with the entirety of the prior year. The NOL does not expire and will be used to offset future pretax income. We expect our long-term effective tax rate to be 26%.

Net Loss and Comprehensive Loss. Net loss and comprehensive loss were $7,014 for the three months ended June 30, 2020 as compared to $15,284 for the three months ended June 30, 2019. The decrease of $8,270 was due to the one-time IPO costs incurred during the prior period having a greater impact than COVID-19 and the Greenwood restructuring costs in the current period.

EBITDA and EBITDA Margin. EBITDA and EBITDA Margin were ($743) and -1.2%, respectively, for the three months ended June 30, 2020 as compared to ($8,102) and -5.6%, respectively, for the three months ended June 30, 2019. The $7,359 increase in EBITDA was primarily due to one-time IPO costs incurred during the prior period having a greater impact than COVID-19 and the Greenwood restructuring costs in the current period.

Adjusted EBITDA and Adjusted EBITDA Margin. Adjusted EBITDA and Adjusted EBITDA Margin were $2,254 and 3.6%, respectively, for the three months ended June 30, 2020, as compared to $18,179 and 12.5%, respectively, for the three months ended June 30, 2019. The decrease in Adjusted EBITDA of $15,925 was primarily due to the adverse impacts of COVID-19 in the current period.

Six Months Ended June 30, 2020 Compared to Six Months Ended June 30, 2019

(in thousands)

Six Months Ended June 30, 2020 Amount % of Net Sales 2019 Amount % of Net Sales Increase (Decrease) Amount Change % Change
Net sales $171,187 100.0% $288,862 100.0% $(117,675) -40.7%
Cost of sales 160,497 93.8% 248,748 86.1% (88,251) -35.5%
Manufacturing margins 10,690 6.2% 40,114 13.9% (29,424) -73.4%
Amortization of intangibles 5,353 3.1% 5,353 1.9% — 0.0%
Profit sharing, bonuses and deferred compensation 2,519 1.5% 24,580 8.5% (22,061) -89.8%
Employee stock ownership plan expense — 0.0% 3,000 1.0% (3,000) -100.0%
Other selling, general and administrative expenses 10,153 5.9% 14,228 4.9% (4,075) -28.6%
Contingent consideration revaluation — 0.0% 3,544 1.2% (3,544) -100.0%
Loss from operations (7,335) -4.3% (10,591) -3.7% (3,256) -30.7%
Interest expense (1,463) 0.9% (4,824) 1.7% (3,361) -69.7%
Loss on extinguishment of debt — 0.0% (154) 0.1% (154) -100.0%
Benefit for income taxes (1,834) -1.1% (2,744) -0.9% (910) -33.2%
Net loss and comprehensive loss $(6,964) -4.1% $(12,825) -4.4% $(5,861) -45.7%
EBITDA $9,104 5.3% $5,610 1.9% $3,494 62.3%
Adjusted EBITDA $13,683 8.0% $34,968 12.1% $(21,285) -60.9%

Net Sales. Net sales were $171,187 for the six months ended June 30, 2020 as compared to $288,862 for the six months ended June 30, 2019 for a decrease of $117,675, or, 40.7%. This change is primarily attributed to the continued impact of market demand changes and related destocking activities during the first quarter of the current year, which was most apparent in the Commercial Vehicle, Agricultural and Construction end markets served, along with manufacturing volume reductions driven by COVID-19 in the second quarter of the current year due to forced customer plant shutdowns, which averaged 5-6 weeks per customer.

Manufacturing Margins. Manufacturing margins were $10,690 for the six months ended June 30, 2020 as compared to $40,114 for the six months ended June 30, 2019, a decrease of $29,424, or, 73.4%. The decline was mainly driven by reduced sales volumes due to the aforementioned market demand changes that continued through the first quarter of the current year, coupled with the impact of customer shutdowns due to COVID-19 in the second quarter of the current year. In addition, cost of sales includes approximately $775 of inventory obsolescence and health care charges specific to the estimated potential impacts of COVID-19. Further, the second quarter of the current year included $1,838 of restructuring costs that were charged to cost of sales related to the Greenwood facility closure.

Our traditional methods of determining inventory obsolescence and health care accruals significantly rely upon historical data. When estimating the approximately $775 of COVID-19 reserves, we had neither historical information, nor much other data from which to compute an estimated impact for this type of event. Nevertheless, the Company believes the obvious risk posed by the pandemic may have a financial impact in these areas. This charge for these COVID-19 specific accruals represents our best good faith estimate of the potential financial impact to the Company based on information available to us. We will continue to evaluate and report on our position with respect to these reserves going forward.

Manufacturing margin percentages were 6.2% for the six months ended June 30, 2020 as compared to 13.9%, of net sales for the six months ended June 30, 2019, a decline of 770 basis points. This decline was mostly attributable to the aforementioned impacts of market demand changes, COVID-19, and Greenwood restructuring costs. Based on the cost reduction initiatives enacted, the Company believes manufacturing margin percentages should improve beyond historical percentages when volumes return to historical levels.

As a result of the Greenwood facility closure, future earnings and cash flows will no longer be impacted by the depreciation associated with the assets disposed of or the facility, which the Company plans to sell. Assets disposed of had a net book value of $2,249 with a remaining useful life of approximately 3 years resulting in approximately $750 of annual depreciation expense that will no longer be incurred. The facility has a net book value of $3,263 as of June 30, 2020 with a remaining useful life of approximately 28 years resulting in approximately $115 of annual depreciation expense that will no longer be incurred. In addition, the Company incurred approximately $800 annually for facility maintenance including building and ground maintenance and utilities. Total personnel costs, including benefits associated with the Greenwood facility, were approximately $2,250 for the first quarter 2020 resulting in approximately $9,000 of annual personnel expenses specific to the Greenwood facility that will no longer be incurred. All customer components manufactured at the Greenwood facility are being re-distributed amongst five other MEC manufacturing facilities and will be supported by personnel at those facilities, the costs of which will offset the majority of the $9,000 of annual

Greenwood personnel costs being eliminated. The aforementioned depreciation, facility maintenance and personnel expenses are classified as cost of sales.

Amortization of Intangibles Expense. Amortization of intangibles expense was $5,353 for both the six months ended June 30, 2020, and 2019.

Profit Sharing, Bonuses and Deferred Compensation Expense. Profit sharing, bonuses and deferred compensation expenses were $2,519 for the six months ended June 30, 2020 as compared to $24,580 for the six months ended June 30, 2019, a decrease of $22,061, or 89.8%. This change was primarily driven by $20,080 of one-time IPO expenses incurred in the prior year including $10,159 for deferred compensation and $9,921 for long-term incentive plan. The remaining decrease of $1,981 is due the elimination of executive bonus and most discretionary gain sharing accruals as a result of lower financial performance attributable to COVID-19, slightly offset by increases in stock-based compensation expense.

Employee Stock Ownership Plan Expense. Employee stock ownership plan expense was zero for the six months ended June 30, 2020 as compared to $3,000, for the six months ended June 30, 2019, a decrease of $3,000, or 100.0%. Prior to December 31, 2019, the annual ESOP contribution was discretionary except that it must be at least 3% of the compensation for all safe harbor participants for the plan year. Beginning in 2020, all contributions are discretionary. The change is due to the decision to eliminate the discretionary accrual made for the three months ended March 31, 2020 during the three month period ended June 30, 2020 as a result of lower forecasted financial performance for the fiscal year 2020 due to the impacts of COVID-19.

Other Selling, General and Administrative Expenses. Other selling, general and administrative expenses were $10,153 for the six months ended June 30, 2020 as compared to $14,228 for the six months ended June 30, 2019, a decrease of $4,075, or 28.6%. The prior year period includes $4,388 of one-time other IPO and DMP acquisition related expenses. Excluding these one-time charges, these expenses increased $313. The increase was driven by a higher amount of public company costs in the current period offset by synergies achieved through the integration of DMP, lower travel and entertainment expenses in the second quarter of the period due to COVID-19 restrictions, and other cost saving initiatives initiated in the current year.

Contingent Consideration Revaluation. The DMP purchase agreement provided for a payout to the previous shareholders of DMP of $7,500, but not more than $10,000 if a certain level of EBITDA was generated during the twelve-month period ended September 30, 2019. We estimated the fair value of the contingent consideration payable balance of $6,076 as of the acquisition date of December 14, 2018. We then remeasured the fair value each quarter through September 30, 2019, with the change recorded as a contingent consideration revaluation adjustment. For the six months ended June 30, 2019, the contingent consideration payable was revalued to $9,598, resulting in $3,544 of a revaluation adjustment for the six months ended June 30, 2019.

At the end of the earnout period, and as agreed to by DMP’s former shareholders, it was determined that DMP’s EBITDA fell short of the payout threshold. As a result, the contingent consideration payable balance was subsequently adjusted to zero, reversing the contingent consideration revaluation adjustments recorded through the periods covered in this report.

Interest Expense. Interest expense was $1,463 for the six months ended June 30, 2020 as compared to $4,824, a decrease of $3,361, or 69.7%. The change is due to lower borrowings during the first half of 2020 as compared to the same prior year period along with lower interest rates attributable to the more favorable terms afforded under the Credit Agreement.

Benefit for Income Taxes. Income tax benefit was $1,834 for the six months ended June 30, 2020 as compared to income tax benefit of $2,744 for the six months ended June 30, 2019. The change is due to a pretax loss in the current period as compared to pretax income for the same prior year period. As of June 30, 2020, NOL carryforward was approximately $23,600 driven by the pretax losses incurred during the current period and the entirety of the prior year. The NOL does not expire and will be used to offset future pretax income.

Net Loss and Comprehensive Loss. Net loss and comprehensive loss were $6,964 for the six months ended June 30, 2020 as compared to $12,825 for the six months ended June 30, 2019. The decrease of $5,861 was due to the previously discussed items.

EBITDA and EBITDA Margin. EBITDA and EBITDA Margin were $9,104 and 5.3%, respectively, for the six months ended June 30, 2020 as compared to $5,610 and 1.9%, respectively, for the six months ended June 30, 2019. The $3,494 increase in EBITDA was primarily due to one-time IPO costs incurred during the prior period having a greater impact than the reduction in sales volumes driven by the decline in market demand, destocking activities and the effects of COVID-19, along with the Greenwood facility closure costs in the current period.

Adjusted EBITDA and Adjusted EBITDA Margin. Adjusted EBITDA and Adjusted EBITDA Margin were $13,683 and 8.0%, respectively, for the six months ended June 30, 2020 as compared to $34,968 and 12.1%, respectively, for the six months ended

June 30, 2019. The decrease in Adjusted EBITDA of $21,285 was primarily due to the reduction in sales volumes in the current period driven by the decline in market demand, destocking activities and the effects of COVID-19.

Liquidity and Capital Resources

Cash Flows Analysis

(in thousands)

Six Months Ended June 30, 2020 2019 Increase (Decrease) $Change % Change
Net cash provided by operating activities $3,111 $6,459 (3,348) -51.8%
Net cash used in investing activities (1,886) (18,981) 17,095 90.1%
Net cash provided by (used in) financing activities (1,106) 9,434 (10,540) -111.7%
Net change in cash $119 $(3,088) $3,207 103.9%

Operating Activities. Cash provided by operating activities was $3,111 for the six months ended June 30, 2020, as compared to $6,459 for the six months ended June 30, 2019. The $3,348, or 51.8% decrease in operating cash flows was primarily due to the COVID-19 impacts on the business in the current period primarily to accounts payable, inventory, and certain accruals. More specifically, in preparing for the uncertainties of COVID-19, the Company ordered additional raw materials to insure against potential supply chain disruptions. When COVID-19 resulted in reduced manufacturing volumes, payables came due for higher manufacturing volume periods along with the extra materials purchased to insure against potential supply chain disruptions, resulting in payment and a reduction of $14,356 in accounts payable. Alternatively, this impact was slightly offset by volume declines driven by COVID-19 resulting in a $3,936 improvement in inventory along with an increase to the excess and obsolete inventory reserve. Changes to pricing, payment terms and credit terms did not have a significant impact on changes to working capital items, or any other element of the operating cash flow activities, for the periods presented.

Investing Activities. Cash used in investing activities was $1,886 for the six months ended June 30, 2020, as compared to $18,981 for the six months ended June 30, 2019. The $17,095, or 90.1% decrease in cash used in investing activities was driven by our capital spend changing from a focus on investments in new technology and automation in 2019 to leveraging those investments and preserving cash in 2020. In addition, due to the Greenwood facility closure, the company generated more proceeds for the sale of equipment in the current period as compared to the same prior year period.

Financing Activities. Cash used in financing activities was $1,106 for the six months ended June 30, 2020, as compared to cash provided by financing activities of $9,434 for the six months ended June 30, 2019. The $10,540 change was driven by greater amount of net IPO proceeds than what was used to pay down debt in the prior year.

Amended and Restated Credit Agreement

On September 26, 2019, and as last amended as of June 30, 2020, we entered into the amended and restated credit agreement (Credit Agreement) with certain lenders and Wells Fargo Bank, National Association, as administrative agent (the Agent). The Credit Agreement provides for a $200,000 Revolving Loan, with a letter of credit sub-facility in an aggregate amount not to exceed $5,000, and a swingline facility in an aggregate amount of $20,000. The Credit Agreement also provides for an additional $100,000 of capacity through an accordion feature. All amounts borrowed under the Credit Agreement mature on September 26, 2024.

Our obligations under the Credit Agreement are secured by first priority security interests in substantially all of our personal property and guaranteed by, and secured by first priority security interests in, substantially all of the personal property of, our direct and indirect subsidiaries: Center Manufacturing, Inc., Center Manufacturing Holdings, Inc., Center—Moeller Products LLC, Defiance Metal Products Co., Defiance Metal Products of Arkansas, Inc., Defiance Metal Products of PA., Inc. and Defiance Metal Products of WI, Inc.

Borrowings under the Credit Agreement bear interest at a fluctuating LIBOR (which may be adjusted for certain reserve requirements), plus 1.00-2.00% depending on the current Consolidated Total Leverage Ratio (as defined in the Credit Agreement). Under certain circumstances, we may not be able to pay interest based on LIBOR. If that happens, we will be required to pay interest at the Base Rate, which is the sum of (a) the higher of (i) the Prime Rate (as publicly announced by the Agent from time to time) and (ii) the Federal Funds Rate plus 0.50%, plus (b) 0.00% to 1.00%, depending on the current Total Consolidated Leverage Ratio. The Credit Agreement also includes provisions for determining a replacement rate when LIBOR is no longer available.

At June 30, 2020, the interest rate on outstanding borrowings under the Revolving Loan was 1.938%. At June 30, 2020, we had availability of $125.5 million under the Revolving Loan.

We must pay a commitment fee at a rate of 0.20% per annum on the average daily unused portion of the aggregate unused revolving commitments under the Credit Agreement. We must also pay fees as specified in the Fee Letter (as defined in the Credit Agreement) and with respect to any letters of credit issued under the Credit Agreement.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on our ability to, subject to certain exceptions, create, incur or assume indebtedness, create or incur liens, make certain investments, merge or consolidate with another entity, make certain asset dispositions, pay dividends or other distributions to shareholders, enter into transactions with affiliates, enter into sale leaseback transactions or make capital expenditures. The Credit Agreement also requires us to satisfy certain financial covenants, including a minimum interest coverage ratio of 3.00 to 1.00. At June 30, 2020, our interest coverage ratio was 7.38 to 1.00. The Credit Agreement also requires us to maintain a consolidated total leverage ratio not to exceed 3.25 to 1.00, although such leverage ratio can be increased in connection with certain acquisitions.

The Credit Agreement includes customary events of default, including, among other things, payment default, covenant default, breach of representation or warranty, bankruptcy, cross-default, material ERISA events, material money judgments, failure to maintain subsidiary guarantees and a change in control, which will be deemed to occur if any person or group other than the ESOP or the 401(k) Plan owns or controls more than 35% of our equity interests. If an event of default occurs, the Agent will be entitled to take various actions, including the acceleration of amounts due under the Credit Agreement, termination of the credit facility, and all other actions permitted to be taken by a secured creditor.

Second Amendment to the Credit Agreement

On June 30, 2020, the Company entered into an amendment (Second Amendment) to the Credit Agreement dated as of September 26, 2019. The Second Amendment provides the Company with temporary relief regarding a financial covenant (the consolidated total leverage ratio) for the period from June 30, 2020, through December 31, 2021, or such earlier date as the Company may elect (Covenant Relief Period), in return for certain increases in interest rates and fees and restrictions on certain activities of the Company, including capital expenditures, acquisitions, dividends and share repurchases. New pricing, which takes effect for the quarters ended on and after September 30, 2020, includes interest at a fluctuating LIBOR (at a floor of 75 basis points), plus 1.00% – 2.75%, along with the commitment fee ranging from 20 to 50 basis points.

During the Covenant Relief Period, the required ceiling on the Company’s consolidated total leverage ratio will be 4.25 to 1.00 for quarters ending June 30, 2020 through and including December 31, 2020, and will decline in quarterly increments to 3.25 to 1.00 for the quarter ending December 31, 2021.

As of June 30, 2020, our consolidated total leverage ratio was 2.35 to 1.00 in accordance with the Second Amendment of the Credit Agreement.

At June 30, 2020, we were in compliance with all covenants under the Credit Agreement and the Second Amendment.

Capital Requirements and Sources of Liquidity

During the six months ended June 30, 2020 and 2019, our capital expenditures were approximately $3,700 and $16,600, respectively. The decrease of approximately $12,900 was driven by shifts in focuses from investments in new technology and automation in 2019 to leveraging those investments and controlling spend in 2020. Capital expenditures for the full year 2020 are expected to be approximately $10,000 to $13,000. The greater the adverse impact COVID-19 has on the business, the closer we expect to be on the lower end of this range.

We have historically relied upon cash available through credit facilities, in addition to cash from operations, to finance our working capital requirements and to support our growth. At June 30, 2020, we had immediate availability of approximately $125,500 through our Revolving Loan and another $100,000 through an accordion feature under our Credit Agreement. We regularly monitor potential capital sources, including equity and debt financings, in an effort to meet our planned capital expenditures and liquidity requirements. Our future success will be highly dependent on our ability to access outside sources of capital. We will continue to have access to the availability currently provided under the Credit Agreement as long as we remain compliant with the financial covenants. Based on our estimates of the impact of COVID-19 at this time, we expect to be in compliance with these financial covenants through 2020 and beyond.

We believe that our operating cash flow and available borrowings under the Credit Agreement are sufficient to fund our operations for 2020 when taking into consideration the estimated impacts of COVID-19 based on the information we have available at this time. However, future cash flows are subject to a number of variables, and additional capital expenditures will be required to conduct our operations. There can be no assurance that operations and other capital resources will provide cash in sufficient amounts to maintain planned or future levels of capital expenditures. In the event we make one or more acquisitions and the amount of capital required is greater than the amount we have available for acquisitions at that time, we could be required to reduce the expected level of capital expenditures and/or seek additional capital. If we seek additional capital, we may do so through borrowings under the Credit

Agreement, joint ventures, asset sales, offerings of debt or equity securities or other means. We cannot guarantee that this additional capital will be available on acceptable terms or at all. If we are unable to obtain the funds we need, we may not be able to complete acquisitions that may be favorable to us or finance the capital expenditures necessary to conduct our operations.

Contractual Obligations

The following table presents our obligations and commitments to make future payments under contracts and contingent commitments at June 30, 2020:

(in thousands)

Total Payments Due by Period 2020 (Remainder) 2021 – 2022 2023 – 2024 Thereafter
Long-term debt principal payment obligations (1) $74,472 $— $— $74,472 $—
Forecasted interest on debt payment obligations (2) 6,252 721 2,886 2,645 —
Capital lease obligations 3,309 367 1,468 1,248 226
Operating lease obligations 12,658 1,702 5,270 3,406 2,280
Total $96,691 $2,790 $9,624 $81,771 $2,506

(1) The long-term amounts in the table include principal payments under the Company’s Credit Agreement, which expires in 2024 and other debt.

(2) Forecasted interest on debt obligations based on the debt balance and interest rate as of June 30, 2020.

Market risk

As filed, 2,324 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risk from changes in customer forecasts, interest rates, and, to a lesser extent, commodities. To reduce such risks, we selectively use financial instruments and other proactive management techniques.

Customer Forecasts

The use and consumption of our components, products and services fluctuates depending on order forecasts we receive from our customers. These order forecasts can change dramatically from quarter to quarter dependent upon the respective markets that our customers provide products in.

Interest Rate Risk

We are exposed to interest rate risk on certain of our short- and long-term debt obligations used to finance our operations and acquisitions. We have LIBOR-based floating rate borrowings under the Credit Agreement, which exposes us to variability in interest payments due to changes in the referenced interest rates.

The amount borrowed under the Revolver Loan under the Credit Agreement was $74.5 million as of June 30, 2020. The interest rate was 1.938% as of June 30, 2020. Please see “Liquidity and Capital Resources - Amended and Restated Credit Agreement” in Part I, Item 2 of this Quarterly Report on Form 10-Q and Note 4 in the Notes to the Unaudited Condensed Consolidated Financial Statements for more specifics.

A hypothetical 100-basis-point increase in interest rates would have resulted in an additional $0.2 million of interest expense based on our variable rate debt at June 30, 2020. We do not use derivative financial instruments to manage interest risk or to speculate on future changes in interest rates. A rise in interest rates could negatively affect our cash flow.

Commodity Risk

We source a wide variety of materials and components from a network of suppliers. While such materials are generally available from numerous suppliers, commodity raw materials, such as steel, aluminum, copper, paint and paint chemicals, and other production costs are subject to price fluctuations, which could have a negative impact on our results. We strive to pass along such commodity price increases to customers to avoid profit margin erosion and in many cases utilize contracts with those customers to mitigate the impact of commodity raw material price fluctuations. As of June 30, 2020, we did not have any commodity hedging instruments in place.

Controls and procedures

As filed, 6,846 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. In designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired objectives.

Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. As a result of the material weakness described below, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were not effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

As a newly public company, neither we nor our independent registered public accounting firm are required at this time to perform an evaluation of our internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act, and neither we nor our independent registered public accounting firm have performed such an evaluation.

During the course of the quarterly and year-end processes in 2019, we identified a material weakness in the design and operation of our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness relates to a lack of consistently documented accounting policies and procedures and a lack of formalized controls over the accounting and recording of complex and significant unusual transactions which, in the aggregate, constitute a material weakness.

We have taken numerous steps to enhance our internal control environment during 2019 and to date in 2020. While preparing for our initial public offering, as of December 31, 2018, we had identified two material weaknesses in the design and operation of our internal control over financial reporting. As of December 31, 2019, we have concluded that one of the previously identified material weaknesses has been remediated and the other has been partially remediated. The previously identified deficiencies, that represented the two material weaknesses, included the preparation and review of journal entries, a limited number of personnel with a level of GAAP accounting knowledge commensurate with our financial reporting requirements and certain information technology general controls specific to segregation of duties, systems access and change management processes. However, deficiencies in our control environment, specifically deficiencies related to a lack of consistently documented accounting policies and procedures and a lack of formalized controls over the accounting and recording of complex and significant unusual transactions, which we have collectively determined aggregate to a material weakness, remained as of June 30, 2020. We are currently evaluating a number of steps to enhance our control over financial reporting and address this material weakness, including: enhancing our internal review procedures during the financial statement close process, and designing and implementing consistent policies throughout the Company; however, our current efforts to design and implement effective controls may not be sufficient to remediate the material weakness described above or prevent future material weaknesses or other deficiencies from occurring. Despite these actions, we may identify additional material weaknesses in our internal control over financial reporting in the future.

If we fail to effectively remediate this material weakness in our internal control over financial reporting, if we identify future material weaknesses in our internal control over financial reporting or if we are unable to comply with the demands that will be placed upon us as a public company, including the requirements of Section 404 of the Sarbanes-Oxley Act, in a timely manner, we may be unable to accurately report our financial results, or report them within the timeframes required by the SEC. In addition, if we are unable to assert that our internal control over financial reporting is effective, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, when required, investors may lose confidence in the accuracy and completeness of our financial reports, we may face restricted access to the capital markets and our stock price may be adversely affected.

Commencing with our Annual Report on Form 10-K for the year ending December 31, 2020 we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting in our Form 10-K filing for that year, as required by Section 404 of the Sarbanes Oxley Act. We expect to expend significant resources in developing the necessary documentation and testing procedures required by Section 404. If we fail to implement the requirements of Section 404 in a timely manner, regulatory authorities such as the SEC or the Pubic Company Accounting Oversight Board, might subject us to sanctions or investigation. We cannot be certain that the actions we will be taking to improve our internal controls over financial reporting will be sufficient, or that we will be able to implement our planned processes and procedures in a timely manner.

Risk factors

As filed, 451 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2019, which was filed with the SEC on March 2, 2020, other than as such were previously supplemented and amended in Part II, Item 1A, “Risk Factors” in our Quarterly Report on Form 10-Q for the three months ended March 31, 2020 which was filed with the SEC on May 6, 2020.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$62.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2020-01-01 to 2020-06-30$171.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-04-01 to 2020-06-30$63.7mus-gaap:CostOfRevenue
Cost of revenue6 months2020-01-01 to 2020-06-30$160.5mus-gaap:CostOfRevenue
Operating income3 months2020-04-01 to 2020-06-30−$8.9mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30−$7.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-04-01 to 2020-06-30$637.0kus-gaap:InterestExpense
Interest expense6 months2020-01-01 to 2020-06-30$1.5mus-gaap:InterestExpense
Income tax3 months2020-04-01 to 2020-06-30−$2.5mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2020-01-01 to 2020-06-30−$1.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-04-01 to 2020-06-30−$7.0mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30−$7.0mus-gaap:NetIncomeLoss
Operating cash flow6 months2020-01-01 to 2020-06-30$3.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$3.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2020-01-01 to 2020-06-30$2.5mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-06-30$120.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$86.4mus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$343.9mus-gaap:Assets
Current liabilitiesAt period end2020-06-30$30.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-06-30$144.9mus-gaap:Liabilities
Shareholders' equityAt period end2020-06-30$199.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-20-036903. Last ingested by Listed: Nov 5, 2026, 13:59 ET. Listed shows no prices and gives no investment advice.